Table: Santen Pharm -2022/23 parent results

SANTEN PHARMACEUTICAL

11/05/2023 07:00

May 11 (Reuters)- 
          Santen Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                    Year ended      Year ended       Year to       NEXT   
                 Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                    LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS          RESULTS       FORECAST    H1 FORECAST 
  Sales             196.59          190.83                                
                  (+3.0 pct)      (+2.5 pct)                              
  Operating          24.80           21.39                                
                 (+15.9 pct)      (-9.4 pct)                              
  Recurring          27.07           22.53                                
                 (+20.2 pct)      (-11.1 pct)                             
  Net             loss 59.38         17.43                                
                                  (-19.9 pct)                             
  EPS          loss 153.18 yen     43.59 yen                              
  EPS Diluted                      43.53 yen                              
  Ann Div         32.00 yen        32.00 yen      32.00 yen               
  -Q2 Div         16.00 yen        16.00 yen      16.00 yen               
  -Q4 Div         16.00 yen        16.00 yen      16.00 yen               
  
  NOTE - Santen Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4536.T